Biomedical Engineering
-
BME alumnus Ash Jayagopal named Chief Scientific Officer of Opus Genetics
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreOct. 21, 2021
-
Two Vanderbilt biomedical engineers lead top academic societies in their fields
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreSep. 21, 2021
-
Cynthia Reinhart-King is president-elect of the Biomedical Engineering Society
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreSep. 20, 2021
-
Discovery points to new avenues to kill aggressive cancer cells
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreAug. 3, 2021
-
Grissom awarded inaugural Course Improvement Grant to support teaching excellence
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreJul. 26, 2021
-
Class of 2021: Family bonds inspire biomedical engineering major to fight breast cancer through cellular research
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreMay. 12, 2021
-
Faculty, students to honor late professor Matthew Walker III in virtual memorial May 8
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreMay. 4, 2021
-
Schwager is one of 100 Ph.D. students in U.S., Canada named P.E.O. Scholar
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreApr. 28, 2021
-
BME Professor Matthew Walker III was biomedical design leader
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreApr. 27, 2021
-
Three elected to College of Fellows of American Institute for Medical and Biological Engineering
Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read MoreMar. 10, 2021